First UK real-world study shows promise for sacituzumab govitecan in metastatic breast cancer Post author: Post published:April 26, 2024 Post category:uncategorized The real-world safety and efficacy of sacituzumab govitecan (SG) against metastatic triple-negative breast cancer. You Might Also Like Can too much exercise strain the heart? October 10, 2025 Bio-inspired drug restores the effectiveness of immune cells in fighting cancer October 9, 2023 Study reports increase in leg and foot amputations in Illinois hospitals from 2016 to 2023 October 31, 2025
Study reports increase in leg and foot amputations in Illinois hospitals from 2016 to 2023 October 31, 2025